tiprankstipranks
Trending News
More News >
SANVO Fine Chemicals Group Limited (HK:0301)
:0301
Hong Kong Market
Advertisement

SANVO Fine Chemicals Group Limited (0301) AI Stock Analysis

Compare
0 Followers

Top Page

HK:0301

SANVO Fine Chemicals Group Limited

(0301)

Select Model
Select Model
Select Model
Neutral 56 (OpenAI - 4o)
Rating:56Neutral
Price Target:
HK$2.00
▲(33.33% Upside)
The overall stock score of 56 reflects significant financial challenges, particularly in profitability and leverage, despite some positive cash flow trends. Technical analysis indicates strong bullish momentum, but the overbought RSI suggests caution. Valuation metrics are weak due to negative earnings and lack of dividends.
Positive Factors
Revenue Growth
The company has shown a revenue growth rate of 35.4%, indicating strong demand for its products and an expanding market presence.
Cash Flow Improvement
Improved operating cash flow and positive free cash flow suggest better cash management and potential for reinvestment in growth initiatives.
Product Innovation
Continued investment in R&D supports product innovation, helping the company meet evolving client needs and maintain competitive advantage.
Negative Factors
High Leverage
High leverage with a debt-to-equity ratio of 1.25 poses financial risks, potentially limiting flexibility and increasing vulnerability to economic downturns.
Profitability Challenges
Negative net profit margin highlights significant profitability challenges, affecting the company's ability to generate sustainable earnings.
Declining EBIT Margins
Decreasing EBIT and EBITDA margins indicate operational inefficiencies, which could hinder long-term profitability and competitiveness.

SANVO Fine Chemicals Group Limited (0301) vs. iShares MSCI Hong Kong ETF (EWH)

SANVO Fine Chemicals Group Limited Business Overview & Revenue Model

Company DescriptionSANVO Fine Chemicals Group Limited (0301) is a leading player in the fine chemicals sector, specializing in the production and distribution of high-quality chemical products. The company operates primarily in the specialty chemicals market, catering to various industries including pharmaceuticals, agriculture, and industrial applications. SANVO’s core offerings include custom synthesis, specialty intermediates, and other fine chemical products that meet the specific needs of its diverse clientele.
How the Company Makes MoneySANVO Fine Chemicals Group Limited generates revenue through multiple channels, primarily by offering tailored chemical solutions to its customers in various industries. The company’s revenue model is based on the sale of fine chemicals, which includes both standard products and custom synthesis services. Key revenue streams are derived from long-term contracts with pharmaceutical and agricultural companies that require specialized chemical formulations. Additionally, SANVO benefits from strategic partnerships with industry leaders, which enhance its market reach and product development capabilities. The company's ability to innovate and adapt its offerings based on market demands also plays a crucial role in sustaining its earnings.

SANVO Fine Chemicals Group Limited Financial Statement Overview

Summary
SANVO Fine Chemicals Group Limited exhibits mixed financial health. The company struggles with profitability as evidenced by negative net income and declining EBIT margins. While cash flow improvements are visible, significant leverage and reduced equity position highlight potential financial risks. Stabilizing revenues and enhancing operational efficiency are critical for future growth.
Income Statement
45
Neutral
The company experienced a decline in revenue from 2023 to 2024. Gross profit margin is stable around 29-30%, but the net profit margin turned negative due to substantial losses, indicating profitability challenges. EBIT and EBITDA margins have also decreased significantly, highlighting issues with operational efficiency.
Balance Sheet
55
Neutral
The balance sheet shows an increase in total assets, but the debt-to-equity ratio is high at 1.25, signaling significant leverage. The equity ratio remains modest, suggesting moderate financial stability. Return on equity has deteriorated due to negative net income, posing potential risks.
Cash Flow
60
Neutral
Operating cash flow increased notably from 2023, and free cash flow turned positive. However, the free cash flow to net income ratio is low, reflecting operational struggles. The company shows signs of improving cash generation but faces profitability challenges.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue1.07B1.06B1.08B947.85M983.11M839.99M
Gross Profit329.48M314.44M311.94M260.99M261.92M268.94M
EBITDA4.11M7.03M34.97M20.71M28.77M81.85M
Net Income-32.13M-19.93M6.21M4.49M14.02M65.82M
Balance Sheet
Total Assets901.55M875.45M773.33M789.36M717.96M665.11M
Cash, Cash Equivalents and Short-Term Investments48.95M61.32M38.18M90.50M17.93M77.17M
Total Debt263.90M267.62M230.80M243.87M197.72M182.46M
Total Liabilities696.14M661.17M541.50M567.71M485.50M438.40M
Stockholders Equity205.41M214.28M231.79M221.65M232.46M226.71M
Cash Flow
Free Cash Flow5.64M19.37M4.84M18.71M-3.62M12.18M
Operating Cash Flow74.05M88.80M42.89M58.60M54.30M110.97M
Investing Cash Flow-64.69M-92.83M-60.86M-8.34M-83.36M-116.84M
Financing Cash Flow-32.28M22.89M-32.58M26.67M-32.72M68.21M

SANVO Fine Chemicals Group Limited Technical Analysis

Technical Analysis Sentiment
Positive
Last Price1.50
Price Trends
50DMA
1.35
Positive
100DMA
1.36
Positive
200DMA
1.22
Positive
Market Momentum
MACD
0.05
Positive
RSI
54.18
Neutral
STOCH
47.37
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:0301, the sentiment is Positive. The current price of 1.5 is above the 20-day moving average (MA) of 1.48, above the 50-day MA of 1.35, and above the 200-day MA of 1.22, indicating a bullish trend. The MACD of 0.05 indicates Positive momentum. The RSI at 54.18 is Neutral, neither overbought nor oversold. The STOCH value of 47.37 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:0301.

SANVO Fine Chemicals Group Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
75
Outperform
HK$749.26M6.4620.67%8.02%25.95%44.12%
69
Neutral
$1.07B8.303.36%7.97%-5.37%25.20%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
56
Neutral
HK$616.30M-17.73-14.53%0.35%-153.95%
54
Neutral
HK$684.44M-23.59-1.52%5.28%0.37%-331.54%
49
Neutral
HK$397.87M-3.96-8.05%-24.13%-27.54%
45
Neutral
HK$142.00M-2.29-15.93%-25.21%12.04%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:0301
SANVO Fine Chemicals Group Limited
1.50
0.36
31.58%
HK:0408
Yip's Chemical Holdings
1.90
0.55
40.74%
HK:0701
CNT Group Limited
0.20
-0.05
-19.20%
HK:1932
CPM Group Ltd.
0.12
-0.13
-52.00%
HK:1986
Tsaker New Energy Tech Co., Limited
0.84
0.04
5.00%
HK:0640
Infinity Development Holdings Co. Ltd.
2.62
1.09
71.24%

SANVO Fine Chemicals Group Limited Corporate Events

SANVO Fine Chemicals Announces Share Awards to Employees
Nov 10, 2025

SANVO Fine Chemicals Group Limited has announced the grant of 8,835,300 award shares to 157 employees under its 2023 Share Award Scheme. This initiative aims to incentivize employees, with shares vesting by November 2026, provided continuous employment is maintained. The grant does not include performance targets but has a clawback mechanism for specific misconduct, potentially impacting employee retention and motivation strategies.

The most recent analyst rating on (HK:0301) stock is a Hold with a HK$1.00 price target. To see the full list of analyst forecasts on SANVO Fine Chemicals Group Limited stock, see the HK:0301 Stock Forecast page.

SANVO Fine Chemicals Releases 2025 Interim Results
Aug 29, 2025

SANVO Fine Chemicals Group Limited announced its unaudited consolidated results for the first half of 2025, highlighting the company’s compliance with the Hong Kong Stock Exchange’s listing rules. The interim report will be accessible on the company’s website and the Stock Exchange’s website, providing stakeholders with detailed insights into the company’s performance.

The most recent analyst rating on (HK:0301) stock is a Hold with a HK$1.00 price target. To see the full list of analyst forecasts on SANVO Fine Chemicals Group Limited stock, see the HK:0301 Stock Forecast page.

SANVO Fine Chemicals Issues Profit Warning Amid Rising Expenses
Aug 25, 2025

SANVO Fine Chemicals Group Limited has issued a profit warning, expecting to record a loss of approximately RMB11.4 million for the six months ended June 30, 2025. This marks a significant increase in losses compared to the same period in 2024, primarily due to heightened marketing, advertising, and promotion expenses.

The most recent analyst rating on (HK:0301) stock is a Hold with a HK$1.50 price target. To see the full list of analyst forecasts on SANVO Fine Chemicals Group Limited stock, see the HK:0301 Stock Forecast page.

SANVO Fine Chemicals Schedules Board Meeting for Interim Results
Aug 19, 2025

SANVO Fine Chemicals Group Limited has announced a board meeting scheduled for August 29, 2025, to approve the interim results for the first half of the year and consider an interim dividend. This meeting could potentially impact the company’s financial performance and shareholder returns, reflecting its ongoing business strategies and market positioning.

The most recent analyst rating on (HK:0301) stock is a Hold with a HK$1.50 price target. To see the full list of analyst forecasts on SANVO Fine Chemicals Group Limited stock, see the HK:0301 Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 12, 2025